Silexion Therapeutics announces immediate exercise of warrants
Silexion Therapeutics entered into definitive agreements for the immediate exercise of outstanding series E warrants.
Silexion Therapeutics entered into definitive agreements for the immediate exercise of outstanding series E warrants.